Bioinformatic characterization of post-translational modifications related to the T30I missense mutation in the ferritin light chain protein and its effect on hyperferritinemia with cataracts
PDF (Spanish)

Keywords

Ferritin
Hyperferritinemia with cataracts-HHCS
Wnt/β-catenin pathway
Cataracts

How to Cite

Gómez-Hernández, M., Soto-Ospina, A., & Villegas- Lanau, A. (2025). Bioinformatic characterization of post-translational modifications related to the T30I missense mutation in the ferritin light chain protein and its effect on hyperferritinemia with cataracts. Revista De La Academia Colombiana De Ciencias Exactas, Físicas Y Naturales. https://doi.org/10.18257/raccefyn.3228

Societal impact


Abstract

Ferritin is a highly conserved protein; however, mutations in its primary sequence may be associated with various diseases. Among them is hyperferritinemia with cataracts, related to the T30I missense mutation in the ferritin light chain, for which some molecular mechanisms have been proposed, but the role of the post-translational modifications involved has not yet been fully elucidated. Here, we performed a bioinformatic characterization of the post-translational modifications altered by this mutation using database searches and predictive tools such as NetNGlyc 1.0, NetOGlyc 4.0, NetPhos 3.1, and Reactome. The analyses suggest a loss of phosphorylation at serine 33 by the CKI kinase, which affects the Wnt/β-catenin signaling pathway. These results support the hypothesis that alterations in the post-translational modifications of the ferritin light chain may constitute a potential molecular mechanism related to cataract development in hereditary hyperferritinemia.

PDF (Spanish)

References

Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., Alkalay, I. (2002). Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes & Development, 16(9), 1066-1076. https://doi.org/10.1101/GAD.230302

Beaumont, C., Leneuve, P., Devaux, I., Scoazec, J. Y., Berthier, M., Loiseau, M. N., Grandchamp, B., Bonneau, D. (1995). Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nature Genetics, 11(4), 444-446. https://doi.org/10.1038/NG1295-444;KWRD

Blom, N., Gammeltoft, S., Brunak, S. (1999). Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. Journal of Molecular Biology, 294(5), 1351-1362.

Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S., Brunak, S. (2004). Prediction of posttranslational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics, 4(6), 1633-1649.

Brooks, D., Todorova, K., Farmer, J., Lobmayr, L., Wilson, R., Eagle, R. (2002). Ferritin Crystal Cataracts in Hereditary Hyperferritinemia Cataract Syndrome. Investigative Ophthalmology & Visual Science, 43(4), 1121-1126. https://iovs.arvojournals.org/article.aspx?articleid=2200177

Carrillo-Esper, R., Peña-Pérez, C., Zepeda-Mendoza, A. D., Meza-Márquez, J. M., Neri-Maldonado, R., Meza-Ayala, C. M., Carrillo-Córdova, D. M., Carrillo-Córdova, C. A. (2015). Ferritina y síndrome hiperferritinémico. Su impacto en el enfermo grave; conceptos actuales. Revista de La Asociación Mexicana de Medicina Critica y Terapia Intensiva, 29(3), 157-166. http://www.scielo.org.mx/pdf/rammcti/v29n3/v29n3a6.pdf

Chang-Godinich, A., Ades, S., Schenkein, D., Brooks, D., Stambolian, D., Raizman, M. B. (2001). Lens changes in hereditary hyperferritinemia-cataract syndrome. American Journal of Ophthalmology, 132(5), 786-788. https://doi.org/10.1016/S0002-9394(01)01106-0

Craig, J., Clark, B., McLeod, J., Kirkland, M., Grant, G., Elder, J., Toohey, M., Kowal, L., Savoia, H., Chen, C., Roberts, S., Wirth, G., Mackey, D. (2003a). Hereditary Hyperferritinemia-Cataract Syndrome: Prevalence, Lens Morphology, Spectrum of Mutations, and Clinical Presentations. Archives of Ophthalmology, 121(12), 1753-1761. https://doi.org/10.1001/ARCHOPHT.121.12.1753

Craig, J., Clark, J. B., McLeod, J., Kirkland, M., Grant, G., Elder, J., Toohey, M., Kowal, L., Savoia, H., Chen, C., Roberts, S., Wirth, M. G., Mackey, D. (2003b). Hereditary Hyperferritinemia-Cataract Syndrome: Prevalence, Lens Morphology, Spectrum of Mutations, and Clinical Presentations. Archives of Ophthalmology, 121(12), 1753-1761. https://doi.org/10.1001/ARCHOPHT.121.12.1753

Elsayed, M. E., Sharif, M. U., Stack, A. G. (2016). Transferrin Saturation: A Body Iron Biomarker. Advances in Clinical Chemistry, 75, 71-97. https://doi.org/10.1016/BS.ACC.2016.03.002

Eris, T., Yanik, A. M., Demirtas, D., Yilmaz, A. F., Toptas, T. (2023). Hereditary Hyperferritinemia-Cataract Syndrome in a Family With HFE-H63D Mutation. Cureus, 15(3), e36253. https://doi.org/10.7759/CUREUS.36253

Fabregat, A., Korninger, F., Viteri, G., Sidiropoulos, K., Marin-Garcia, P., Ping, P., Wu, G., Stein, L., D’Eustachio, P., Hermjakob, H. (2018). Reactome graph database: Efficient access to complex pathway data. PLoS Computational Biology, 14(1), e1005968. https://doi.org/10.1371/JOURNAL.PCBI.1005968

Fujimura, N. (2016). WNT/β-catenin signaling in vertebrate eye development. Frontiers in Cell and Developmental Biology, 4(NOV), 221674. https://doi.org/10.3389/FCELL.2016.00138/BIBTEX

Giansily-Blaizot, M., Cunat, S., Moulis, G., Schved, J. F., Aguilar-Martínez, P. (2013). Homozygous mutation of the 5’UTR region of the L-Ferritin gene in the hereditary hyperferritinemia cataract syndrome and its impact on the phenotype. Haematologica, 98(4), e43. https://doi.org/10.3324/HAEMATOL.2012.077198

Girelli, D., Ouvieri, O., Franceschi, L. De, Corrocher, R., Bergamaschi, G., Cazzola, M. (1995). A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. British Journal of Haematology, 90(4), 931-934. https://doi.org/10.1111/J.1365-2141.1995.TB05218.X

Gómez-Hernández, M., Soto-Ospina, A., Osorio, C. A., Villegas-Lanau, A. (2024). Structural Analysis of Variants of the Ferritin Light Chain Protein and Its Relationship with Neuroferritinopathy. ACS Chemical Neuroscience, 15(24), 4402-4417. https://doi.org/10.1021/ACSCHEMNEURO.4C00400

Gupta, R. & Brunak, S. (2002). Prediction of glycosylation across the human proteome and the correlation to protein function. Pacific Symposium on Biocomputing, 2002, 310-322.

Iqbal, H., Yang, T., Li, T., Zhanga, M., Ke, H., Ding, D., Deng, Y., Chen, H. (2021). Serum proteinbased nanoparticles for cancer diagnosis and treatment. Journal of Controlled Release, 329, 997-1022. https://doi.org/10.1016/j.jconrel.2020.10.030

Kaarniranta, K., Zin, O. A., Neves, L. M., Cunha, D. P., Motta, F. L., Agonigi, B. N. S., Horovitz, D. D. G., Almeida, D. C., Malacarne, J., Paula, A., Rodrigues, S., Carvalho, A. B., Rivello, C. A., Espariz, R., Zin, A. A., Sallum, J. M. F., Vasconcelos, Z. F. M., Br, A. Z. (2023). Genotypic-Phenotypic Correlations of Hereditary Hyperferritinemia-Cataract Syndrome: Case Series of Three Brazilian Families. International Journal of Molecular Sciences, 24(15). https://doi.org/10.3390/ijms241511876

Kannengiesser, C., Jouanolle, A. M., Hetet, G., Mosser, A., Muzeau, F., Henry, D., Bardou-Jacquet, E., Mornet, M., Brissot, P., Deugnier, Y., Grandchamp, B., Beaumont, C. (2009). A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica, 94(3), 335-339. https://doi.org/10.3324/HAEMATOL.2008.000125

Khan, M. A., Mohammad, T., Malik, A., Hassan, M. I., Domashevskiy, A. V. (2023). Iron response elements (IREs)-mRNA of Alzheimer’s amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach. Scientific Reports, 13(1), 1-17. https://doi.org/10.1038/S41598-023-32073-X;SUBJMETA

Lachlan, K. L., Temple, I. K., Mumford, A. D. (2004). Clinical features and molecular analysis of seven British kindreds with hereditary hyperferritinaemia cataract syndrome. European Journal of Human Genetics 2004 12:10, 12(10), 790-796. https://doi.org/10.1038/sj.ejhg.5201252

Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., He, X. (2002). Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 108(6), 837-847. https://doi.org/10.1016/S0092-8674(02)00685-2

Milacic, M., Beavers, D., Conley, P., Gong, C., Gillespie, M., Griss, J., Haw, R., Jassal, B., Matthews, L., May, B., Petryszak, R., Ragueneau, E., Rothfels, K., Sevilla, C., Shamovsky, V., Stephan, R., Tiwari, K., Varusai, T., Weiser, J., … D’Eustachio, P. (2024). The Reactome Pathway Knowledgebase 2024. Nucleic Acids Research, 52(D1), D672-D678. https://doi.org/10.1093/NAR/GKAD1025

Moravikova, J., Honzik, T., Jadvidzakova, E., Zdrahalova, K., Kremlikova Pourova, R., Korbasova, M., Liskova, P., Dudakova, L. (2020). Hereditary hyperferritinemia-cataract syndrome in three Czech families: molecular genetic testing and clinical implications. Journal of American Association for Pediatric Ophthalmology and Strabismus, 24(6), 352.e1-352.e5. https://doi.org/10.1016/J.JAAPOS.2020.07.014

Neves, J., Haider, T., Gassmann, M., Muckenthaler, M. U. (2019). Iron Homeostasis in the Lungs—A Balance between Health and Disease. Pharmaceuticals, 12(1), 5. https://doi.org/10.3390/PH12010005

Nos, F., Hernández, G., Ferrer, X., Hernandez, I., Navarro, B., Fuster, J. L., Cortés, M. B., Pérez, S., Tornador, C., Sánchez, M. (2021). Hereditary hyperferritinemia cataract syndrome: Ferritin l gene and physiopathology behind the disease—report of new cases. International Journal of Molecular Sciences, 22(11), 5451. https://doi.org/10.3390/IJMS22115451/S1

Sandnes, M., Ulvik, R. J., Vorland, M., Reikvam, H. (2021). Hyperferritinemia—A Clinical Overview. Journal of Clinical Medicine, 10(9), 2008. https://doi.org/10.3390/JCM10092008

Steentoft, C., Vakhrushev, S., Joshi, H., Kong, Y., Vester-Christensen, M., Schjoldager, K., Lavrsen, K., Dabelsteen, S., Pedersen, N., Gupta, R., Bennett, E., Mandel, U., Brunak, S., Wandall, H., Levery, S., Clausen, H. (2013). Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J, 32(10), 1478-1488.

Torti, F. M. & Torti, S. V. (2002). Regulation of ferritin genes and protein. Blood, 99(10), 3505-3516. https://doi.org/10.1182/BLOOD.V99.10.3505

Yang, Y., Lin, T., Kuang, P., Chen, X. (2021). Ferritin L-subunit gene mutation and hereditary hyperferritinaemia cataract syndrome (HHCS): a case report and literature review. Hematology (United Kingdom), 26(1), 896-903. https://doi.org/10.1080/16078454.2021.1995111

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales

Downloads

Download data is not yet available.